Loading...
XNYS
CNC
Market cap15bUSD
Jul 11, Last price  
31.44USD
1D
-3.32%
1Q
-50.77%
Jan 2017
11.29%
IPO
2,161.87%
Name

Centene Corp

Chart & Performance

D1W1MN
XNYS:CNC chart
No data to show
P/E
4.73
P/S
0.10
EPS
6.64
Div Yield, %
Shrs. gr., 5y
4.49%
Rev. gr., 5y
16.92%
Revenues
163.07b
+5.89%
1,505,864,0002,279,020,0002,919,292,0003,364,515,0004,102,864,0004,448,323,0005,340,582,0008,667,612,00010,863,329,00016,560,000,00022,760,000,00040,607,000,00048,382,000,00060,116,000,00074,639,000,000111,115,000,000125,982,000,000144,547,000,000153,999,000,000163,071,000,000
Net income
3.31b
+22.32%
55,632,000-43,629,00073,402,00083,497,00083,671,00094,836,000111,218,0001,859,000165,099,000271,000,000355,000,000562,000,000828,000,000900,000,0001,321,000,0001,808,000,0001,347,000,0001,202,000,0002,702,000,0003,305,000,000
CFO
154m
-98.09%
74,048,000195,032,000202,240,000221,978,000248,195,000168,932,000261,696,000278,691,000382,526,0001,223,000,000658,000,0001,851,000,0001,489,000,0001,234,000,0001,483,000,0005,503,000,0004,205,000,0006,261,000,0008,053,000,000154,000,000
Earnings
Jul 24, 2025

Profile

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
IPO date
Dec 13, 2001
Employees
74,300
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
163,071,000
5.89%
153,999,000
6.54%
144,547,000
14.74%
Cost of revenue
128,436,000
122,458,000
127,891,000
Unusual Expense (Income)
NOPBT
34,635,000
31,541,000
16,656,000
NOPBT Margin
21.24%
20.48%
11.52%
Operating Taxes
963,000
899,000
760,000
Tax Rate
2.78%
2.85%
4.56%
NOPAT
33,672,000
30,642,000
15,896,000
Net income
3,305,000
22.32%
2,702,000
124.79%
1,202,000
-10.76%
Dividends
Dividend yield
Proceeds from repurchase of equity
(3,078,000)
(1,589,000)
(3,026,000)
BB yield
9.70%
3.92%
6.34%
Debt
Debt current
268,000
287,000
82,000
Long-term debt
20,057,000
19,638,000
21,251,000
Deferred revenue
Other long-term liabilities
1,829,000
2,738,000
5,616,000
Net debt
(13,789,000)
(16,013,000)
(7,746,000)
Cash flow
Cash from operating activities
154,000
8,053,000
6,261,000
CAPEX
(644,000)
(799,000)
(1,004,000)
Cash from investing activities
(1,052,000)
(1,191,000)
(2,921,000)
Cash from financing activities
(2,406,000)
(1,658,000)
(4,197,000)
FCF
34,020,000
30,659,000
16,855,000
Balance
Cash
16,685,000
19,652,000
14,395,000
Long term investments
17,429,000
16,286,000
14,684,000
Excess cash
25,960,450
28,238,050
21,851,650
Stockholders' equity
14,855,000
11,508,000
8,390,000
Invested Capital
32,913,000
36,231,000
39,483,000
ROIC
97.40%
80.94%
38.53%
ROCE
71.48%
65.19%
34.35%
EV
Common stock shares outstanding
523,744
545,704
582,040
Price
60.58
-18.37%
74.21
-9.51%
82.01
-0.47%
Market cap
31,728,412
-21.65%
40,496,694
-15.16%
47,733,100
-1.90%
EV
17,949,412
24,599,694
40,167,100
EBITDA
35,876,000
32,834,000
18,209,000
EV/EBITDA
0.50
0.75
2.21
Interest
702,000
725,000
665,000
Interest/NOPBT
2.03%
2.30%
3.99%